Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Galectin Therapeutics Inc. - Common Stock
(NQ:
GALT
)
3.880
-0.170 (-4.20%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Galectin Therapeutics Inc. - Common Stock
< Previous
1
2
3
Next >
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
December 19, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Which stocks are moving on Friday?
↗
December 19, 2025
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via
Chartmill
Why Did GALT Shares Plummet Over 30% Today?
↗
December 19, 2025
Via
Stocktwits
Which stocks are gapping on Friday?
↗
December 19, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Galectin Therapeutics: Q3 Earnings Insights
↗
November 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 15, 2025
Via
Benzinga
Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
September 25, 2025
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday. Shares of Stitch Fix, Inc. (NASDAQ: SFIX) dipped 7.6% to $5.21 in pre-market trading following the...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 15, 2025
Via
Benzinga
Galectin Beats Q2 Loss Estimates
↗
August 14, 2025
Via
The Motley Fool
Topics
Intellectual Property
12 Health Care Stocks Moving In Friday's After-Market Session
↗
July 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
June 20, 2025
Via
Benzinga
These stocks are moving in today's session
↗
June 20, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
June 18, 2025
Via
Benzinga
These stocks are moving in today's session
↗
June 17, 2025
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
June 17, 2025
Via
Benzinga
Which stocks are moving on Tuesday?
↗
June 17, 2025
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
December 20, 2024
Via
Benzinga
Dow Surges Over 600 Points, Gold Jumps 1.5%
↗
December 20, 2024
Via
Benzinga
Topics
Stocks
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
↗
December 20, 2024
Via
Benzinga
Dow Surges 100 Points, Carnival Earnings Top Views
↗
December 20, 2024
Via
Benzinga
Topics
Stocks
Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday?
↗
December 20, 2024
Galectin Therapeutics' NAVIGATE trial shows belapectin reduces varices in MASH cirrhosis, but falls short of statistical targets; full data due in early 2025.
Via
Benzinga
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q2 2024
↗
August 13, 2024
GALT stock results show that Galectin Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Galectin Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
↗
July 24, 2024
Via
Benzinga
GALT Stock Earnings: Galectin Therapeutics Misses EPS for Q1 2024
↗
May 15, 2024
GALT stock results show that Galectin Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Galectin Therapeutics And 2 Other Penny Stocks Insiders Are Buying
↗
April 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
April 05, 2024
Via
Benzinga
GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023
↗
April 05, 2024
GALT stock results show that Galectin Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
↗
March 17, 2024
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
Via
The Motley Fool
More Personal Portfolio: Biotech, Commodities, And Gold
↗
September 24, 2023
In a few years we will know if that was an extraordinarily opportunistic moment, or a long and frustrating rabbit hole.
Via
Talk Markets
Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
↗
July 21, 2023
The Dow Jones closed higher by more than 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
